Breaking News Instant updates and real-time market news.

2019-11-04 08:56:39 ATVI Activision Blizzard $55.81 -0.25 (-0.45%) 08:56 11/04/19 11/04 08:56 11/04/19 08:56	Activision Blizzard price target raised to $65 from $60 at BMO Capital BMO Capital analyst Gerrick Johnson raised his price target on Activision Blizzard to $65 and kept his Outperform rating following the BlizzCon opening ceremonies and his meeting with its management in Anaheim, CA. The analyst notes that the company has "delivered" on the "high expectations" with announcements for Diablo 4 and Overwatch 2 titles, adding that the management was also "very optimistic" about Activision's overall pipeline. Johnson adds that the long lines for the Diablo 4 demo as well as online commentary give him confidence in the strong demand for the title.	07 Nov
ATVI Activision Blizzard $55.81 -0.25 (-0.45%) 10/28/19 RHCO 10/28/19 NO CHANGE Target $59 RHCO Buy SunTrust says 'Modern Warfare' U.K. sales data 'clearly' points positive SunTrust analyst Matthew Thornton reiterated a Buy rating and $59 price target on Activision Blizzard, noting that U.K. week one physical sales of "Call of Duty: Modern Warfare" rose 39% versus last year's "Call of Duty: Black Ops 4," according to GfK via Gamesindustry.biz. The analyst said that assuming a starting point of 20M units for "Black Ops 4," that digital mix last year was 40%, and that digital mix is up five points to 45% this year, this would imply total unit growth of over 50% or over 10M year-over-year for the franchise. Thornton said he isn't getting "too carried away," but noted this data "clearly" points positive relative to expectations. 10/30/19 PIPR 10/30/19 NO CHANGE Target $62 PIPR Overweight Piper says Activision's latest 'Call of Duty' selling better than expected After Activision Blizzard announced this morning that "Call of Duty: Modern Warfare" had more than $600M in sell-through worldwide in its first three days of release, marking the highest first three-day sell through of any "Call of Duty" in the current console cycle, Piper Jaffray analyst Michael Olson said the game is selling better than expected based on these initial sales trends. Olson thinks even "slight upside" in the company's upcoming Q3 report on November 17 could lead to a FY19 guidance raise if the company has increasing confidence in "Modern Warfare," he added. Olson keeps an Overweight rating and $62 price target on Activision Blizzard shares. 11/04/19 PIPR 11/04/19 NO CHANGE Target $62 PIPR Overweight Activision Blizzard has put 'lethargic 2019 behind it,' says Piper Jaffray Piper Jaffray analyst Michael Olson is confident that Activision Blizzard "has put a lethargic 2019 behind it and can rebound in 2020." Overwatch 2 and Diablo 4, which were unveiled Friday, along with the next World of Warcraft expansion, Shadowlands in 2020, and an expansion to Hearthstone represent "material growth potential" over the next two years, Olson tells investors in a research note. The analyst also sees upside potential from World of Warcraft Classic when Activision reports on November 7. He maintains an Overweight rating on the shares with a $62 price target. 11/04/19 SPHN 11/04/19 NO CHANGE Target $65 SPHN Overweight Stephens would be a buyer of Activision shares if weak ahead of earnings Stephens analyst Jeff Cohen said he believes the announcements made by Activision Blizzard at BlizzCon were largely in-line with investors' expectations and that early impressions of Diablo 4, Overwatch 2, and the Warcraft expansion have been "largely positive." While he could see some short-term pressure on shares due to the lack of release dates for Diablo and Overwatch, he would be a buyer of the stock on any weakness ahead of this week's earnings report, Cohen said. The analyst, who believes Overwatch 2 will be released in 2020 and Diablo 4 will come in 2021, keeps an Overweight rating and $65 price target on Activision Blizzard shares.

2019-11-04 08:56:39

ATVI

Activision Blizzard

$55.81: -0.25 (-0.45%)

08:56

11/04/19

11/04

08:56

11/04/19

08:56

Activision Blizzard price target raised to $65 from $60 at BMO Capital

BMO Capital analyst Gerrick Johnson raised his price target on Activision Blizzard to $65 and kept his Outperform rating following the BlizzCon opening ceremonies and his meeting with its management in Anaheim, CA. The analyst notes that the company has "delivered" on the "high expectations" with announcements for Diablo 4 and Overwatch 2 titles, adding that the management was also "very optimistic" about Activision's overall pipeline. Johnson adds that the long lines for the Diablo 4 demo as well as online commentary give him confidence in the strong demand for the title.

07
Nov

ATVI Activision Blizzard

$55.81: -0.25 (-0.45%)

10/28/19: RHCO

10/30/19: PIPR

11/04/19: PIPR

11/04/19: SPHN

TODAY'S FREE FLY STORIES

PHOT GrowLife $0.00 (0.00%) 09:04 12/13/19 12/13 09:04 12/13/19 09:04 Hot Stocks	GrowLife announces distributorship agreement with High Plains Crop Production » GrowLife announced its… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
CERN Cerner $71.81 0.35 (0.49%) 09:02 12/13/19 12/13 09:02 12/13/19 09:02 Hot Stocks	Cerner board of directors authorizes additional $1.5B share repurchase » Cerner announced that its… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
SIRI Sirius XM $6.88 0.01 (0.15%) 09:01 12/13/19 12/13 09:01 12/13/19 09:01 Hot Stocks	Sirius XM announces exclusive radio broadcast agreement with Rolling Loud » SiriusXM announced that… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
SNAP Snap $14.45 0.22 (1.55%) , SRPT Sarepta $100.39 -1.15 (-1.13%) … 09:01 12/13/19 12/13 09:01 12/13/19 09:01 Hot Stocks	Fly Intel: Pre-market Movers » UP AFTER EARNINGS: Adobe… UP AFTER EARNINGS: Adobe (ADBE), up 2%. ALSO HIGHER: Snap (SNAP), up 2% after JMP Securities analyst Ronald Josey upgraded the stock to Outperform from Market Perform with a $20 price target. The analyst is "incrementally confident" in Snap's ability to grow its user base, increase engagement, and improve overall monetization as the service attracts more advertisers and share of advertising budgets... Xperi (XPER), up 2% after raising Q4 and FY19 billings outlook... Exelixis (EXEL), up 4% after Genentech announced the Phase III IMspire150 study met its primary endpoint of progression-free survival. In late 2006, Exelixis entered into a worldwide collaboration agreement with Genentech, under which Exelixis received initial upfront and milestone payments for signing the agreement and submitting the IND... Sarepta (SRPT), up 32% after announcing that the FDA has approved VYONDYS 53, an antisense oligonucleotide indicated for the treatment of Duchenne muscular dystrophy in patients with a confirmed mutation amenable to exon 53 skipping. DOWN AFTER EARNINGS: Oracle (ORCL), down 2%... Broadcom (AVGO), down 1%. ALSO LOWER: Patterson-UTI (PTEN), down 2% after JPMorgan analyst Sean Meakim downgraded shares to Underweight from Neutral with a price target of $6, down from $7... Anixa Biosciences (ANIX), down 2% after announcing optimization work for its CAR-T therapy may take an additional year, resulting in the filing of the IND in late 2020, with clinical trials to commence in 2021... Aquestive Therapeutics (AQST), down 18% after its 7M share secondary priced at $5.00 per share. SNAP Snap $14.45 0.22 (1.55%) SRPT Sarepta $100.39 -1.15 (-1.13%) ADBE Adobe $305.76 2.01 (0.66%) ORCL Oracle $56.47 0.16 (0.28%) XPER Xperi $19.91 0.44 (2.26%) EXEL Exelixis $17.68 0.05 (0.28%) AVGO Broadcom $327.39 7.53 (2.35%) ANIX Anixa Biosciences $3.82 -0.05 (-1.29%) PTEN Patterson-UTI $10.38 0.29 (2.87%) AQST Aquestive Therapeutics $6.73 -0.97 (-12.60%) 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	07 Jan 23 Jan 06 Feb 13 Dec
DHR Danaher $151.34 1.58 (1.06%) , GE General Electric $11.44 0.46 (4.19%) … 08:55 12/13/19 12/13 08:55 12/13/19 08:55 Options	Notable open interest changes for December 13th » Thursday's total… DHR Danaher $151.34 1.58 (1.06%) GE General Electric $11.44 0.46 (4.19%) AMD AMD $42.61 3.16 (8.01%) NVST Envista $28.47 0.29 (1.03%) Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	29 Jan

LULU Lululemon $224.48 -8.83 (-3.78%) 08:52 12/13/19 12/13 08:52 12/13/19 08:52 Recommendations	Lululemon analyst commentary » Lululemon price target… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	13 Dec
08:51 12/13/19 12/13 08:51 12/13/19 08:51 Conference/Events	Credit Suisse economists/strategists to hold an analyst/industry conference call » Economists and… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial
TREE LendingTree $293.67 -13 (-4.24%) 08:51 12/13/19 12/13 08:51 12/13/19 08:51 Recommendations	LendingTree analyst commentary » Stephens says LendingTree… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
SBGI Sinclair Broadcast $30.95 -0.77 (-2.43%) 08:50 12/13/19 12/13 08:50 12/13/19 08:50 Initiation	Sinclair Broadcast initiated » Sinclair Broadcast… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
LEVI Levi Strauss $18.41 0.39 (2.16%) 08:49 12/13/19 12/13 08:49 12/13/19 08:49 Recommendations	Levi Strauss analyst commentary » Levi Strauss price target… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial

UTI Universal Technical $6.98 -0.27 (-3.72%) 08:48 12/13/19 12/13 08:48 12/13/19 08:48 Syndicate	Universal Technical 3.6M share Spot Secondary priced at $6.25 » B. Riley FBR acted as… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
AVGO Broadcom $327.39 7.53 (2.35%) 08:46 12/13/19 12/13 08:46 12/13/19 08:46 Recommendations	Broadcom analyst commentary » Broadcom price target… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
08:45 12/13/19 12/13 08:45 12/13/19 08:45 General news	U.S. import prices increased 0.2% » U.S. import prices… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial
AMC AMC Entertainment $8.29 0.12 (1.47%) , SCO Scor ADR $13.01 -0.21 (-1.59%) … 08:45 12/13/19 12/13 08:45 12/13/19 08:45 Options	Largest borrow rate increases among liquid names » Latest data shows the… AMC AMC Entertainment $8.29 0.12 (1.47%) SCO Scor ADR $13.01 -0.21 (-1.59%) PLCE Children's Place $58.26 4.46 (8.29%) CHWY Chewy $27.95 1.08 (4.02%) TLRY Tilray $18.87 0.68 (3.74%) BLDP Ballard Power $6.17 0.095 (1.56%) JDST Direxion Daily Junior Gold Miners Index Bear 3x Shares $12.68 0.11 (0.88%) GTT GTT Communications $12.01 -0.36 (-2.91%) Z Zillow $42.51 -0.22 (-0.51%) SVXY ProShares Short VIX Short-Term Futures $63.16 1.65 (2.68%) Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	16 Dec
08:45 12/13/19 12/13 08:45 12/13/19 08:45 General news	U.S. retail sales increased 0.2% in November, and were up 0.1% excluding autos » U.S. retail sales… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial

08:45 12/13/19 12/13 08:45 12/13/19 08:45 General news	FX Action: The dollar » FX Action: The dollar… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial
VCTR Victory Capital $21.68 0.235 (1.10%) 08:44 12/13/19 12/13 08:44 12/13/19 08:44 Downgrade	Victory Capital rating change » Victory Capital… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
CRBP Corbus Pharmaceuticals $5.08 0.16 (3.25%) 08:43 12/13/19 12/13 08:43 12/13/19 08:43 Conference/Events	Corbus Pharmaceuticals to hold a webinar » Expert panel discusses… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	13 Dec
EV Eaton Vance $47.08 0.395 (0.85%) 08:42 12/13/19 12/13 08:42 12/13/19 08:42 Upgrade	Eaton Vance rating change » Eaton Vance upgraded to… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
TTMI TTM Technologies $13.79 0.19 (1.40%) 08:41 12/13/19 12/13 08:41 12/13/19 08:41 Upgrade	TTM Technologies rating change » JPMorgan upgrades TTM… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial

AJG Arthur J. Gallagher $94.63 0.16 (0.17%) 08:39 12/13/19 12/13 08:39 12/13/19 08:39 Conference/Events	Arthur J. Gallagher to host investor meeting » Investor meeting to be… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	18 Dec
NEWR New Relic $66.87 0.86 (1.30%) 08:38 12/13/19 12/13 08:38 12/13/19 08:38 Recommendations	New Relic analyst commentary » Morgan Stanley came way… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
AMK AssetMark Financial $27.31 0.42 (1.56%) 08:38 12/13/19 12/13 08:38 12/13/19 08:38 Upgrade	AssetMark Financial rating change » JPMorgan upgrades… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
LII Lennox $259.14 0.71 (0.27%) 08:38 12/13/19 12/13 08:38 12/13/19 08:38 Conference/Events	Lennox to host investor meeting » Investor meeting to be… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	18 Dec
VIAC ViacomCBS $37.79 0.52 (1.40%) 08:36 12/13/19 12/13 08:36 12/13/19 08:36 Initiation	ViacomCBS initiated » ViacomCBS reinstated with… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in in 9 minutes Get Free Trial 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial

Events

Earnings calls, analyst events, roadshows and more

PCTY
Today at 09:30

Paylocity Holding Corporation Firm Sponsored Meetings

1400 American Lane, Schaumburg, IL
Today at 10:00

Business Inventories M/M: October 2019 Government Event
RCL
Today at 10:00

Royal Caribbean - RCL Conference Calls
FCEL
Today at 10:00

FuelCell Energy Inc. Firm Sponsored Meetings

90 Park Avenue, 35th Floor, New York, NY
LRN
Today at 10:00

K12, Inc. Firm Sponsored Meetings

555 Eleventh Street, N.W., Suite 1000, Washington, D.C., DC
VLGEA
Today at 10:00

Village Super Market Inc. Firm Sponsored Meetings

733 Mountain Avenue, Springfield, NJ
PVT
Today at 10:00

Pivotal Acquisition Corp. Firm Sponsored Meetings
Today at 10:00

Oilfield Services & Equipment Industry Meetings
ATVI ...
Today at 10:30

Digital Media Industry Meetings
Today at 11:00

Fed Reserve Bank President Williams Speaks on Monetary Policy Government Event

Borough of Manhattan Community College--CUNY--Borough of Manhattan Community College, New York, NY

View All Events »

1 of

Syndicate

This week’s upcoming IPOs and secondary offerings

Priced
Not Priced

Mon	CRWD X CRWD Crowdstrike Block Trade Managers: Goldman Sachs Priced at: $49.40 2.2M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial AUPH X AUPH Aurinia Pharmaceuticals Secondary Managers: Jefferies & SVB Leerink, H.C. Wainwright, Oppenheimer, Bloom Burton Priced at: $15.00 11.1M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial XAIR X XAIR Beyond Air Secondary Managers: SunTrust, National Securities, Roth Capital, Laidlaw Priced at: $3.66 2.325M Shares ABR X ABR Arbor Realty Spot Secondary Managers: JPMorgan, JMP Securities & Raymond James Priced at: $14.14 6.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial CFRX X CFRX ContraFect Spot Secondary Managers: Maxim Priced at: $.27 37.15M Shares RHP X RHP Ryman Hospitality Spot Secondary Managers: BofA/Merrill, JPMorgan & Wells Fargo Priced at: $85.60 3M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SCYX X SCYX Scynexis Spot Secondary Managers: H.C. Wainwright Priced at: $.90 38.89M Shares
Tues	XP X XP XP IPO Managers: Goldman Sachs, JPMorgan, Morgan Stanley, XP & Itau BBA, BofA/Merrill, Citi, Credit Suisse, UBS Priced at: $27.00 72.5M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial CNST X CNST Constellation Pharmaceuticals Spot Secondary Managers: JPMorgan, Jefferies & Cowen, RBC Capital, SunTrust Priced at: $34.50 6.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial GMRE X GMRE Global Medical REIT Spot Secondary Managers: Stifel, BMO Capital, Baird, KeyBanc & SunTrust Priced at: $13.00 6M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial KIDS X KIDS OrthoPediatrics Spot Secondary Managers: Piper Jaffray & Stifel, BTIG, JMP Securities, SunTrust Priced at: $36.50 1.57M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial MDGL X MDGL Madrigal Pharmaceuticals Spot Secondary Managers: Goldman Sachs Priced at: $107.85 1.2M Shares MRNS X MRNS Marinus Pharmaceuticals Spot Secondary Managers: Oppenheimer & Ladenburg Priced at: $1.25 28M Shares PACK X PACK Ranpak Holdings Spot Secondary Managers: Craig-Hallum Priced at: $6.50 15.384M Shares PMT X PMT PennyMac Mortgage Spot Secondary Managers: Morgan Stanley, Credit Suisse, BofA/Merrill, JPMorgan & Barclays, Nomura Instinet, Piper Jaffray Priced at: $22.10 8M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial RCKT X RCKT Rocket Pharmaceuticals Spot Secondary Managers: JPMorgan, Cowen & Evercore ISI, LifeSci Priced at: $22.25 3.82M Shares
Wed	BILL X BILL Bill.com IPO Managers: Goldman Sachs, BofA/Merrill, Jefferies & KeyBanc, Canaccord, Needham, William Blair Priced at: $22.00 9.824M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial EH X EH Ehang IPO Managers: Morgan Stanley, Needham, Tigress Financial, Prime Number Priced at: $12.50 3.2M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial LVGO X LVGO Livongo Health Secondary Managers: Morgan Stanley, Goldman Sachs & JPMorgan Priced at: $27.00 2.78M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial MNRL X MNRL Brigham Minerals Secondary Managers: Credit Suisse, Goldman Sachs & RBC Capital Priced at: $18.10 11M Shares MNTA X MNTA Momenta Secondary Managers: Goldman Sachs & JPMorgan, Stifel Priced at: $15.50 14.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial AKTS X AKTS Akoustis Spot Secondary Managers: Craig-Hallum, Roth Capital, Loop Capital Priced at: $6.25 4.8M Shares ASMB X ASMB Assembly Biosciences Spot Secondary Managers: Jefferies & SVB Leerink Priced at: $16.50 5.152M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial FTSV X FTSV Forty Seven Spot Secondary Managers: Morgan Stanley & Credit Suisse Priced at: $35.00 4.86M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Thurs	LULU X LULU Lululemon Block Trade Managers: Morgan Stanley Priced at: $220.00 2.6M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial HCCO X HCCO Healthcare Merger Corp. IPO Managers: Cantor Fitzgerald Priced at: $10.00 22M Shares OCFT X OCFT OneConnect IPO Managers: Morgan Stanley, Goldman Sachs, JPMorgan & Ping An of China, BofA/Merrill, HSBC, CLSA, KeyBanc Priced at: $10.00 31.2M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SPT X SPT Sprout Social IPO Managers: Goldman Sachs, Morgan Stanley, KeyBanc & William Blair, Canaccord, Stifel Priced at: $17.00 8.824M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial AEMD X AEMD Aethlon Medical Secondary Managers: H.C. Wainwright Priced at: $1.50 3.333M Shares AQST X AQST Aquestive Therapeutics Secondary Managers: BMO Capital Priced at: $5.00 7M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial PHR X PHR Phreesia Secondary Managers: JPMorgan, Wells Fargo, William Blair, Allen & Co., Piper Jaffray, Baird, Raymond James Priced at: $26.00 6.75M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Fri	No deals

Mon	No deals
Tues	No deals
Wed	No deals
Thurs	ASPU X ASPU Aspen Group Spot Secondary Managers: Canaccord $7.55 Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Fri	No deals

View All Syndicate Announcements »

Activision Blizzard price target raised to $65 from $60 at BMO Capital

TODAY'S FREE FLY STORIES

Get Full Fly Access